Skip to main navigation
Who We Are
What We Stand For
Leadership
Advocacy/Unmet Need
Work With Us
Corporate Responsibility
Our Portfolio
RTGel® Technology
JELMYTO®
(mitomycin) for pyelocalyceal solution
Partnerships
Pipeline
Media & Investors
Media
Investors
Connect
We strive to
put patients first
and preserve their future
possibilities
Investor Relations
Overview
News Releases
Events
Financials
Governance
Stock Info
Reports
Resources
UGN-102 Phase 3 ATLAS & ENVISION Topline Data Event
Jul 27, 2023
10:00 AM EDT
Webcast Replay
Back
to top